Cargando…

Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy

Detalles Bibliográficos
Autores principales: Brogden, Kim A., Parashar, Deepak, Hallier, Andrea R., Braun, Terry, Qian, Fang, Rizvi, Naiyer A., Bossler, Aaron D., Milhem, Mohammed M., Chan, Timothy A., Abbasi, Taher, Vali, Shireen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898039/
https://www.ncbi.nlm.nih.gov/pubmed/29649990
http://dx.doi.org/10.1186/s12885-018-4200-5
_version_ 1783314059046682624
author Brogden, Kim A.
Parashar, Deepak
Hallier, Andrea R.
Braun, Terry
Qian, Fang
Rizvi, Naiyer A.
Bossler, Aaron D.
Milhem, Mohammed M.
Chan, Timothy A.
Abbasi, Taher
Vali, Shireen
author_facet Brogden, Kim A.
Parashar, Deepak
Hallier, Andrea R.
Braun, Terry
Qian, Fang
Rizvi, Naiyer A.
Bossler, Aaron D.
Milhem, Mohammed M.
Chan, Timothy A.
Abbasi, Taher
Vali, Shireen
author_sort Brogden, Kim A.
collection PubMed
description
format Online
Article
Text
id pubmed-5898039
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58980392018-04-20 Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy Brogden, Kim A. Parashar, Deepak Hallier, Andrea R. Braun, Terry Qian, Fang Rizvi, Naiyer A. Bossler, Aaron D. Milhem, Mohammed M. Chan, Timothy A. Abbasi, Taher Vali, Shireen BMC Cancer Correction BioMed Central 2018-04-12 /pmc/articles/PMC5898039/ /pubmed/29649990 http://dx.doi.org/10.1186/s12885-018-4200-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Brogden, Kim A.
Parashar, Deepak
Hallier, Andrea R.
Braun, Terry
Qian, Fang
Rizvi, Naiyer A.
Bossler, Aaron D.
Milhem, Mohammed M.
Chan, Timothy A.
Abbasi, Taher
Vali, Shireen
Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
title Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
title_full Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
title_fullStr Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
title_full_unstemmed Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
title_short Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
title_sort correction to: genomics of nsclc patients both affirm pd-l1 expression and predict their clinical responses to anti-pd-1 immunotherapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898039/
https://www.ncbi.nlm.nih.gov/pubmed/29649990
http://dx.doi.org/10.1186/s12885-018-4200-5
work_keys_str_mv AT brogdenkima correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy
AT parashardeepak correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy
AT hallierandrear correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy
AT braunterry correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy
AT qianfang correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy
AT rizvinaiyera correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy
AT bossleraarond correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy
AT milhemmohammedm correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy
AT chantimothya correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy
AT abbasitaher correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy
AT valishireen correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy